Lilly expects $62.4M pre-tax IPR&D and milestone charge in Q3 2022, $0.06 EPS impact

ELI LILLY & Co

Estimated $62.4M pre-tax charge for acquired IPR&D and development milestones in Q3 2022.
Charge translates to $0.06 per share on both GAAP and non-GAAP basis.
Results for Q3 2022 not yet finalized; actuals may differ.
Company does not forecast such charges due to uncertainty of future transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.